When: Q3 2026 earnings mid-October

Then: Full reassessment regardless of price action

HOLD current position; ADD on pullback to ~$336 (50-day MA)

• Q2 EPS of $7.70 annualizes to $30.80 vs full-year consensus of $25.01, implying ~$6 of H2 earnings weakness
• If Q3/Q4 come in at ~$6 each, the multiple expands to ~19x on current price rather than compressing to 15.6x
• NII growth is decelerating: Q3-to-Q4 4.3%, Q4-to-Q1 1.5%, Q1-to-Q2 less than 0.5% — curve flattening hard
• At 86% Polymarket probability of zero cuts, NII expansion is largely priced in with no further catalyst
• 8% recession probability implies ~1 year in 12 of 30-40% drawdown for bank stocks; Polymarket probabilities shift 30 percentage points on single data prints
• JPM's own S&P 8000 call should not be treated as fundamental input when CEO Jamie Dimon simultaneously warns of inflation persistence and dollar reserve currency risk
• Current price at $365 with overhead resistance at $367 and psychological resistance at $370; RSI making lower highs since mid-June = negative momentum divergence
• Downside path: $358, then $352, then $336, then $312; break below $336 opens 50-point gap to 200-day moving average
• Compressed ATR of $6.60 makes tight stops at $358 (7 dollars) counterproductive — position gets stopped out on routine volatility every few sessions
• ATR compression at resistance is energy that releases in both directions, not a guaranteed coiled spring breakout
• 2.7:1 risk-reward cited by aggressive analyst is misleading; upside constrained by resistance while downside has multiple clean air pockets
• Conservative entry: 50-day MA around $336 (9% better entry), stop at $312 = properly asymmetric 3:1 risk-reward on adds
• Breakout confirmation requires price above $367 on volume above 8 million shares

→ vs aggressive: Earnings multiple compression thesis is contradicted by the 6-dollar gap between Q2 annualized EPS ($30.80) and consensus ($25.01) — if consensus is right, multiple EXPANDS to ~19x, not compresses

→ vs aggressive: JPM $8.5B quarterly buyback doesn't guarantee upside when marginal demand from all other buyers is drying up at resistance on compressed volume

→ vs aggressive: NII absolute dollar growth obscures meaningful deceleration: growth rate fell from 4.3% to 1.5% to <0.5% sequentially, with 86% zero-cut probability meaning NII expansion is priced in

→ vs aggressive: Polymarket 8% recession probability and zero-cut pricing are not risk models — probabilities shift 30 percentage points on single CPI/jobs prints; building high-conviction positions on these is leverage on a forecast, not conviction

→ vs aggressive: JPM S&P 8000 bullish call cannot be used selectively while ignoring CEO Jamie Dimon's simultaneous warnings about inflation persistence and dollar reserve currency risk from the same firm

→ vs aggressive: 2.7:1 risk-reward is only valid if upside target ($380) is achievable before resistance ($367/$370) and momentum exhaustion reverse the setup; downside has clean air pockets to $336/$312

→ vs aggressive: ATR compression at upper Bollinger Band is not a coiled spring — it's energy that releases in both directions, equally likely to gap down through 10 EMA as to break out

→ vs aggressive: Tight stop at $358 (10 EMA) on 6.60 ATR is too tight for a compressed-ATR environment at all-time highs; 2 ATRs at $352 gives position room to breathe through normal noise

HOLD - Maintain existing position, build buy ladder at 358/352/336, trim toward neutral ahead of Q3 2026 earnings

• JPM fundamentals intact: 17.8% ROE, $52B annual capital returns, fortress balance sheet
• Buy ladder recommended: 1/3 at 10 EMA (358), 1/3 at 20 SMA (352), 1/3 at 50 SMA (336)
• Conditional breakout add: above 367 on volume >8M shares with tight trailing stop
• Trim toward neutral before Q3 2026 earnings as resolution catalyst for thesis debate
• Stop-loss at 352 (2 ATRs) is correct for existing position; 358 stop too tight, 312 stop only for new adds at 50 SMA
• Current technicals compress risk-reward: RSI approaching 70, price at upper Bollinger Band, declining volume on new highs, ATR compressing at resistance
• PE 15.6x is 40-50% above 5-year average, suggesting limited multiple expansion runway
• Q2 EPS annualization to $30 is flawed; full-year $25 consensus already bakes in normalization
• Consensus $25 EPS already represents analysts doing their job, not bearish evidence

→ vs aggressive: Multiple expansion thesis is a forecast, not a fact; saying JPM 'should trade at 18-20x' layers one bet on top of another

→ vs aggressive: Buyback supply squeeze already priced in; relying on mechanical board-controlled input creates vulnerability if capital allocation policy shifts

→ vs aggressive: 358 stop-loss would manufacture losses in compressed ATR environment; fished out on routine noise

→ vs conservative: Annualizing Q2 EPS ($30) is apples-to-oranges vs full-year consensus ($25); Q2 is structurally strong for capital markets activity

→ vs conservative: Waiting for 50 SMA at 336 is market timing disguised as discipline; the target keeps moving (will be ~345 by the time price arrives)